Literature DB >> 34000130

Cross-Sectional Associations Among Symptoms of Pain, Irritability, and Depression and How These Symptoms Relate to Social Functioning and Quality of Life: Findings From the EMBARC and STRIDE Studies and the VitalSign6 Project.

Manish K Jha1,2, Alan Schatzberg3, Abu Minhajuddin2,4, Cherise Chin Fatt2, Taryn L Mayes2, Madhukar H Trivedi2,5.   

Abstract

OBJECTIVE: The aim of this report was to evaluate the psychometric properties of the Pain Frequency, Intensity, and Burden Scale (P-FIBS), a brief measure of pain, as well as the association of pain with irritability and depression and how these symptoms relate to functional impairments.
METHODS: Participants of 2 randomized controlled trials (Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care [EMBARC; n = 251 with DSM-IV diagnosis of major depressive disorder; study duration: August 2011-December 2015] and STimulant Reduction Intervention Using Dosed Exercise [STRIDE; n = 302 with DSM-IV diagnosis of stimulant abuse or dependence; study-duration: July 2010-February 2013]) and treatment-seeking patients in primary care clinics from an ongoing quality-improvement project (VitalSign6; n = 4,370; project duration: August 2014-July 2019) were included. Psychometric properties of the P-FIBS were evaluated with confirmatory factor and item response theory analyses in EMBARC and VitalSign6. The approach of Baron and Kenny was used to assess whether irritability accounted for the effect of pain on depression.
RESULTS: Cronbach α (0.84-0.89) and model fits for single-factor structure of P-FIBS were acceptable. Pain was positively correlated with irritability (r = 0.22-0.29) and depression (r = 0.10-0.33). Irritability accounted for 40.7%-65.5% of the effect of pain on depression. Higher irritability and depression were associated with poorer social functioning, quality of life, and productivity in work- and non-work-related activities. Pain was associated with non-work-related activity impairments even after controlling for irritability and depression.
CONCLUSIONS: The P-FIBS is a brief and reliable measure of pain. Irritability is associated with pain and accounts for a large proportion of the effect of pain on depression. Symptoms of pain, irritability, and depression are associated with functional impairments. TRIAL REGISTRATION: ClinicalTrials.gov identifiers: NCT01407094 (EMBARC), NCT01141608 (STRIDE). © Copyright 2021 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34000130      PMCID: PMC9578176          DOI: 10.4088/JCP.20m13740

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   5.906


  60 in total

Review 1.  Neuroinflammation and comorbidity of pain and depression.

Authors:  A K Walker; A Kavelaars; C J Heijnen; R Dantzer
Journal:  Pharmacol Rev       Date:  2013-12-11       Impact factor: 25.468

2.  Two-Year Follow-up of a Randomized Clinical Trial of Mindfulness-Based Stress Reduction vs Cognitive Behavioral Therapy or Usual Care for Chronic Low Back Pain.

Authors:  Daniel C Cherkin; Melissa L Anderson; Karen J Sherman; Benjamin H Balderson; Andrea J Cook; Kelly E Hansen; Judith A Turner
Journal:  JAMA       Date:  2017-02-14       Impact factor: 56.272

3.  A Structured Approach to Detecting and Treating Depression in Primary Care: VitalSign6 Project.

Authors:  Manish K Jha; Bruce D Grannemann; Joseph M Trombello; E Will Clark; Sara Levinson Eidelman; Tiffany Lawson; Tracy L Greer; A John Rush; Madhukar H Trivedi
Journal:  Ann Fam Med       Date:  2019-07       Impact factor: 5.166

4.  The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder.

Authors:  Roger S McIntyre; Orly Lipsitz; Nelson B Rodrigues; Yena Lee; Danielle S Cha; Maj Vinberg; Kangguang Lin; Gin S Malhi; Mehala Subramaniapillai; Kevin Kratiuk; Andrea Fagiolini; Hartej Gill; Flora Nasri; Rodrigo B Mansur; Trisha Suppes; Roger Ho; Joshua D Rosenblat
Journal:  Bipolar Disord       Date:  2020-07-08       Impact factor: 6.744

5.  Chronic pain and major depressive disorder in the general population.

Authors:  Maurice M Ohayon; Alan F Schatzberg
Journal:  J Psychiatr Res       Date:  2010-02-09       Impact factor: 4.791

6.  The symptom-specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta-analysis.

Authors:  Lynn Boschloo; Ella Bekhuis; Erica S Weitz; Mirjam Reijnders; Robert J DeRubeis; Sona Dimidjian; David L Dunner; Boadie W Dunlop; Ulrich Hegerl; Steven D Hollon; Robin B Jarrett; Sidney H Kennedy; Jeanne Miranda; David C Mohr; Anne D Simons; Gordon Parker; Frank Petrak; Stephan Herpertz; Lena C Quilty; A John Rush; Zindel V Segal; Jeffrey R Vittengl; Robert A Schoevers; Pim Cuijpers
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

Review 7.  Psychological therapies for the management of chronic and recurrent pain in children and adolescents.

Authors:  Emma Fisher; Emily Law; Joanne Dudeney; Tonya M Palermo; Gavin Stewart; Christopher Eccleston
Journal:  Cochrane Database Syst Rev       Date:  2018-09-29

8.  Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients.

Authors:  Manish K Jha; Abu Minhajuddin; Tracy L Greer; Thomas Carmody; Augustus John Rush; Madhukar H Trivedi
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

Review 9.  The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain.

Authors:  Jiyao Sheng; Shui Liu; Yicun Wang; Ranji Cui; Xuewen Zhang
Journal:  Neural Plast       Date:  2017-06-19       Impact factor: 3.599

10.  VitalSign6: A Primary Care First (PCP-First) Model for Universal Screening and Measurement-Based Care for Depression.

Authors:  Madhukar H Trivedi; Manish K Jha; Farra Kahalnik; Ronny Pipes; Sara Levinson; Tiffany Lawson; A John Rush; Joseph M Trombello; Bruce Grannemann; Corey Tovian; Robert Kinney; E Will Clark; Tracy L Greer
Journal:  Pharmaceuticals (Basel)       Date:  2019-05-14
View more
  2 in total

1.  Mechanisms Underlying Gastrodin Alleviating Vincristine-Induced Peripheral Neuropathic Pain.

Authors:  Xiangyu Wang; Boxuan Zhang; Xuedong Li; Xingang Liu; Songsong Wang; Yuan Xie; Jialing Pi; Zhiyuan Yang; Jincan Li; Qingzhong Jia; Yang Zhang
Journal:  Front Pharmacol       Date:  2021-12-16       Impact factor: 5.810

2.  Selective Orexin Receptor Antagonists as Novel Augmentation Treatments for Major Depressive Disorder: Evidence for Safety and Efficacy From a Phase 2B Study of Seltorexant.

Authors:  Manish Kumar Jha
Journal:  Int J Neuropsychopharmacol       Date:  2022-01-12       Impact factor: 5.176

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.